References
- Foote F WJ, Stewart F W. Lobular carcinoma in situ. A rare form of mammary cancer. Am J Pathol 1941; 17: 491–496
- Wellings S R, Jensen H M, Marcum R G. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 1975; 55: 231–273
- Rosen P P. Rosen's Breast Pathology. Lippincott-Raven, Philadelphia 1997
- Page D L, Anderson T J. Diagnostic Histopathology of the Breast. Churchill Livingstone, New York 1987
- Tavassoli F A, Devilee P. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press, Lyon 2003
- Haagensen C D, Lane N, Lattes R, et al. Lobular neoplasia (so called lobular carcinoma in situ) of the breast. Cancer 1978; 42: 737–769
- Tavassoli F A. Lobular neoplasia (lobular carcinoma in situ). Pathology of the Breast. 2nd ed., Tavassoli FA. Appleton and Lange, Norwalk, CT 1999; 263–291
- Abdel-Fatah T M, Powe D G, Hodi Z, Lee A H, Reis-Filho J S, Ellis I O. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol 2007; 31: 417–426
- Sneige N, Wang J, Baker B A, et al. Clinical, histopathologic and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 2002; 15: 1044–1050
- Jacobs T W, Pliss N, Kouria G, et al. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol 2001; 25: 229–236
- Dabbs D J, Bhargava R, Chivukula M. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin. Am J Surg Pathol 2007; 31: 427–437
- Dabbs D J, Kaplai M, Chivukula M, Kanbour A, Kanbour-Shakir A, Carter G J. The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast. Appl Immunohistochem Mol Morphol 2007; 15: 260–266
- Bratthauer G L, Moinfar F, Stamatakos M D, et al. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol 2002; 33: 620–627
- Buerger H, Simon R, Schäfer K L, et al. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol 2000; 53: 118–121
- Lu Y J, Osin P, Lakhani S R, Di Palma S, Gusterson B A, Shipley J M. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 1998; 58: 4721–4727
- Lakhani S R, Collins N, Sloane J P, Stratton M R. Loss of heterozygosity in lobular carcinoma in situ of the breast. Clin Mol Pathol 1995; 48: M74–M78
- Mastracci T L, Tjan S, Bane A L, O'Malley F P, Andrulis I L. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Mod Pathol 2005; 18: 741–751
- Shelley Hwang E, Nyante S J, Yi Chen Y, et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 2004; 100: 2562–2572
- Vos C B, Cleton-Jansen A M, Berx G, et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997; 76: 1131–1133
- Middleton L P, Palacios D M, Bryant B R, Krebs P, Otis C N, Merino M J. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 2000; 24: 1650–1656
- Reis-Filho J S, Simpson P T, Jones C, et al. Pleomorphic lobular carcinoma in situ of the breast: role of comprehensive molecular pathology in characterization of an entitiy. J Pathol 2005; 207: 1–13
- Palacios J, Sarrió D, García-Macias M C, Bryant B, Sobel M E, Merino M J. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast. Mod Pathol 2003; 16: 674–678
- O'Driscoll D, Britton P, Bobrow L, et al. Lobular carcinoma in situ on core biopsy: what is the clinical significance?. Clin Radiol 2001; 56: 216–220
- Philpotts L E, Shaheen N A, Jain K S, et al. Uncommon high risk lesions of the breast diagnosed at stereotactic core needle biopsy: clinical importance. Radiology 2000; 216: 831–837
- Berg W A, Mrose H E, Ioffe O B. Atypical lobular hyperplasia or lobular carcinoma in-situ at core-needle breast biopsy. Radiology 2001; 218: 503–509
- Shin S J, Rosen P P. Excisional biopsy should be performed if lobular carcinoma in situ is seen on core biopsy. Arch Pathol Lab Med 2002; 126: 697–701
- Cangiarella J, Guth A, Axelrod D, et al. Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literature. Arch Pathol Lab Med 2008; 132: 979–983
- Pacelli A, Rhodes D J, Amrami K K, et al. Outcome of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed by core needle biopsy: clinical and surgical follow-up of 30 cases. Am J Clin Pathol 2001; 116: 591–592
- Middleton L P, Shakeitha G, Stephens T, et al. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?. Mod Pathol 2003; 16: 120–129
- Renshaw A E, Cartagena N, Derhagopian R P. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol 2002; 117: 797–799
- Fadare O, Dadmanesh F, Alvarado-Cabrero I, et al. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases. Am J Surg Pathol 2006; 30: 1445–1453